Drug Side Effects
Search
INFLAMMATION LOCALISED
INFLAMMATION LOCALISED
was reported 37 times
INFLAMMATION LOCALISED is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
1
0.0001
1
Parathyroid Hormone Analog [EPC]
3
0.0000
2
Muscle Relaxant [EPC]
1
0.0000
3
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
4
Sulfonylurea [EPC]
2
0.0000
5
Cardiac Glycoside [EPC]
1
0.0000
6
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
7
beta-Adrenergic Blocker [EPC]
3
0.0000
8
Antirheumatic Agent [EPC]
1
0.0000
9
Mood Stabilizer [EPC]
2
0.0000
10
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
11
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
12
Alkylating Drug [EPC]
2
0.0000
13
Platinum-based Drug [EPC]
2
0.0000
14
alpha-Adrenergic Blocker [EPC]
1
0.0000
15
Leukocyte Growth Factor [EPC]
1
0.0000
16
Loop Diuretic [EPC]
3
0.0000
17
Azole Antifungal [EPC]
1
0.0000
18
Interferon beta [EPC]
1
0.0000
19
Nonsteroidal Anti-inflammatory Drug [EPC]
6
0.0000
20
Anti-epileptic Agent [EPC]
1
0.0000
21
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
22
Vitamin D [EPC]
1
0.0000
23
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
24
Vitamin B12 [EPC]
1
0.0000
25
Benzodiazepine [EPC]
2
0.0000
26
Vitamin C [EPC]
1
0.0000
27
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
28
Proton Pump Inhibitor [EPC]
1
0.0000
29
Corticosteroid [EPC]
2
0.0000